KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Preferred Dividend Payments (2018 - 2019)

Castle Biosciences (CSTL) has disclosed Preferred Dividend Payments for 2 consecutive years, with $2.0 million as the latest value for Q4 2019.

  • Quarterly Preferred Dividend Payments rose 184.12% to $2.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2020, up 486.25% year-over-year, with the annual reading at $2.2 million for FY2019, 884.47% up from the prior year.
  • Preferred Dividend Payments hit $2.0 million in Q4 2019 for Castle Biosciences, up from $17000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $2.0 million in Q4 2019 to a low of -$2.4 million in Q4 2018.